Meeting
2015 Genitourinary Cancers Symposium
Prostate-specific antigen velocity as a predictive biomarker in a prospective prostate cancer screening study (IMPACT study).
Authors
Christos Mikropoulos
Institute of Cancer Research, Sutton, United Kingdom
Christos Mikropoulos , Christina Selkirk , Sibel Saya , Elizabeth Bancroft , Tokhir Dadaev , Charles Brendler , Edward Saunders , Daniel Leongamornlert , Elizabeth Page , Clara Cieza Borrella , The IMPACT study Collaborators And Steering Group , Sue Moss , Zsofia Kote-Jarai , Brian Helfand , Ros A. Eeles
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Clinical Trial Registration Number
NCT00261456
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 16)
DOI
10.1200/jco.2015.33.7_suppl.16
Abstract #
16
Poster Bd #
B8
Abstract Disclosures
Similar Posters
Poster
2014 Genitourinary Cancers Symposium
Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers to detect clinically significant disease: Results from the initial screening round of the IMPACT study.
First Author: Christos Mikropoulos
Poster
2023 ASCO Genitourinary Cancers Symposium
The profile study: Prostate cancer screening in men of Black African and African Caribbean ancestry—Early results.
First Author: Netty Kinsella
Poster
2012 ASCO Annual Meeting
Detecting prostate cancer in BRCA1 and BRCA2 mutation carriers: A role for EN2?
First Author: Emma Killick
Poster
2024 ASCO Genitourinary Cancers Symposium
Prevalence of variant of unknown significance (VUS) in men with prostate cancer who serve as a benchmark for enhanced screening and for personalized therapy.
First Author: Vittorio Fasulo